Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Prisca Boinguérin
Introduction
Prisca Boinguérin is a notable inventor based in Berlin, Germany. She has made significant strides in the field of biotechnology, particularly in the development of therapies for cystic fibrosis. Her work focuses on enhancing the stability and transport of CFTR proteins, which are crucial for cellular function.
Latest Patents
Prisca holds a patent for "Compositions and methods for inhibiting the interaction between CFTR and CAL." This invention features compositions and methods aimed at increasing the cell surface expression of degradation-prone CFTR proteins. It provides innovative peptides and peptidomimetics that selectively inhibit the interaction between CAL and mutant CFTR proteins. This stabilization facilitates the transport of CFTR to the cell surface, offering potential treatments for cystic fibrosis.
Career Highlights
Prisca is affiliated with Dartmouth College, where she contributes to research and development in her field. Her dedication to advancing medical science is evident through her innovative approaches and commitment to improving patient outcomes.
Collaborations
She has collaborated with esteemed colleagues, including Dean R Madden and Patrick R Cushing, to further her research initiatives. These partnerships enhance the impact of her work and foster a collaborative environment for innovation.
Conclusion
Prisca Boinguérin's contributions to biotechnology and her innovative patent for cystic fibrosis treatment highlight her role as a leading inventor in her field. Her work not only advances scientific knowledge but also holds promise for improving the lives of those affected by cystic fibrosis.